Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model

Bioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antisept...

Full description

Bibliographic Details
Main Authors: María I. Quiñones-Vico, Ana Fernández-González, Elena Pérez-Castejón, Trinidad Montero-Vílchez, Salvador Arias-Santiago
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/4/642
id doaj-e4c723a6b1fc40a8ab392c1920c25e7c
record_format Article
spelling doaj-e4c723a6b1fc40a8ab392c1920c25e7c2021-02-09T00:01:03ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-011064264210.3390/jcm10040642Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin ModelMaría I. Quiñones-Vico0Ana Fernández-González1Elena Pérez-Castejón2Trinidad Montero-Vílchez3Salvador Arias-Santiago4Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainBiosanitary Institute of Granada (ibs. GRANADA), 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainBioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antiseptics and antibiotics on cell viability, structural integrity, and epidermal barrier function in BASS based on hyaluronic acid during a 28 day follow-up period. Keratinocytes (KTs) and dermal fibroblasts (DFs) were isolated from skin samples and used to establish BASS. The following antibiotic/antiseptic treatment was applied every 48 h: colistin (1%), chlorhexidine digluconate (1%), sodium chloride (0.02%), and polyhexanide (0.1%). Cell viability (LIVE/DEAD<sup>®</sup> assay), structural integrity (histological evaluation), and epidermal barrier function (trans-epidermal water loss, (TEWL), Tewameter<sup>®</sup>) were also evaluated. Cell viability percentage of BASS treated with chlorhexidine digluconate was significantly lower (<i>p</i> ≤ 0.001) than the other antiseptics at day 28. Compared to other treatments, chlorhexidine digluconate and polyhexanide significantly affected the epithelium. No significant differences were found regarding epidermal barrier. These results may be useful for treatment protocols after implantation of BASS in patients and evaluating them in clinical practice. BASS represent a suitable model to test in vitro the impact of different treatments of other skin wounds.https://www.mdpi.com/2077-0383/10/4/642antiseptic/antibiotic testingbioengineered artificial skin substitutecell viabilityepidermal barrier functionregenerative medicinewound healing
collection DOAJ
language English
format Article
sources DOAJ
author María I. Quiñones-Vico
Ana Fernández-González
Elena Pérez-Castejón
Trinidad Montero-Vílchez
Salvador Arias-Santiago
spellingShingle María I. Quiñones-Vico
Ana Fernández-González
Elena Pérez-Castejón
Trinidad Montero-Vílchez
Salvador Arias-Santiago
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
Journal of Clinical Medicine
antiseptic/antibiotic testing
bioengineered artificial skin substitute
cell viability
epidermal barrier function
regenerative medicine
wound healing
author_facet María I. Quiñones-Vico
Ana Fernández-González
Elena Pérez-Castejón
Trinidad Montero-Vílchez
Salvador Arias-Santiago
author_sort María I. Quiñones-Vico
title Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
title_short Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
title_full Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
title_fullStr Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
title_full_unstemmed Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
title_sort cytotoxicity and epidermal barrier function evaluation of common antiseptics for clinical use in an artificial autologous skin model
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-02-01
description Bioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antiseptics and antibiotics on cell viability, structural integrity, and epidermal barrier function in BASS based on hyaluronic acid during a 28 day follow-up period. Keratinocytes (KTs) and dermal fibroblasts (DFs) were isolated from skin samples and used to establish BASS. The following antibiotic/antiseptic treatment was applied every 48 h: colistin (1%), chlorhexidine digluconate (1%), sodium chloride (0.02%), and polyhexanide (0.1%). Cell viability (LIVE/DEAD<sup>®</sup> assay), structural integrity (histological evaluation), and epidermal barrier function (trans-epidermal water loss, (TEWL), Tewameter<sup>®</sup>) were also evaluated. Cell viability percentage of BASS treated with chlorhexidine digluconate was significantly lower (<i>p</i> ≤ 0.001) than the other antiseptics at day 28. Compared to other treatments, chlorhexidine digluconate and polyhexanide significantly affected the epithelium. No significant differences were found regarding epidermal barrier. These results may be useful for treatment protocols after implantation of BASS in patients and evaluating them in clinical practice. BASS represent a suitable model to test in vitro the impact of different treatments of other skin wounds.
topic antiseptic/antibiotic testing
bioengineered artificial skin substitute
cell viability
epidermal barrier function
regenerative medicine
wound healing
url https://www.mdpi.com/2077-0383/10/4/642
work_keys_str_mv AT mariaiquinonesvico cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel
AT anafernandezgonzalez cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel
AT elenaperezcastejon cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel
AT trinidadmonterovilchez cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel
AT salvadorariassantiago cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel
_version_ 1724278926780399616